Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) EPS (Basic) (2021 - 2026)

Lucid Diagnostics filings provide 5 years of EPS (Basic) readings, the most recent being -$0.1 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 44.44% to -$0.1 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.8, a 24.53% increase, with the full-year FY2025 number at -$0.69, up 34.29% from a year prior.
  • EPS (Basic) hit -$0.1 in Q4 2025 for Lucid Diagnostics, roughly flat from -$0.1 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.08 in Q2 2025 to a low of -$0.52 in Q1 2025.
  • Median EPS (Basic) over the past 5 years was -$0.33 (2023), compared with a mean of -$0.31.
  • Biggest five-year swings in EPS (Basic): tumbled 34.62% in 2022 and later surged 65.22% in 2025.
  • Lucid Diagnostics' EPS (Basic) stood at -$0.32 in 2021, then decreased by 25.0% to -$0.4 in 2022, then soared by 37.5% to -$0.25 in 2023, then rose by 28.0% to -$0.18 in 2024, then soared by 44.44% to -$0.1 in 2025.
  • The last three reported values for EPS (Basic) were -$0.1 (Q4 2025), -$0.1 (Q3 2025), and -$0.08 (Q2 2025) per Business Quant data.